[article] 
inJournal of Autism and Developmental Disorders > 50-9 (September 2020) . - p.3114-3125

Titre :	Parent Perspectives Towards Genetic and Epigenetic Testing for Autism Spectrum Disorder
Type de document :	Texte imprimé et/ou numérique
Auteurs :	Kayla E. WAGNER, Auteur ; Jennifer B. MCCORMICK, Auteur ; Sarah BARNS, Auteur ; Molly CARNEY, Auteur ; Frank A. MIDDLETON, Auteur ; Steven D. HICKS, Auteur
Article en page(s) :	p.3114-3125
Langues :	Anglais (eng)
Mots-clés :	Autism  Bioethics  Diagnosis  Epigenetics  Parent perspectives  biomarkers in autism spectrum disorder that is assigned to The Research Foundation  for the State University of New York, The Penn State Research Foundation and  Quadrant Biosciences Inc., and licensed to Quadrant Biosciences Inc. SDH is a paid  consultant for Quadrant Biosciences Inc. These conflicts of interest are actively  managed by the Penn State College of Medicine. KW and SB are employees of Quadrant  Biosciences Inc.
Index. décimale :	PER Périodiques
Résumé :	Examining community views on genetic/epigenetic research allows collaborative technology development. Parent perspectives toward genetic/epigenetic testing for autism spectrum disorder (ASD) are not well-studied. Parents of children with ASD (n?=?131), non-ASD developmental delay (n?=?39), and typical development (n?=?74) completed surveys assessing genetic/epigenetic knowledge, genetic/epigenetic concerns, motives for research participation, and attitudes/preferences toward ASD testing. Most parents (96%) were interested in saliva-based molecular testing for ASD. Some had concerns about privacy (14%) and insurance-status (10%). None (0%) doubted scientific evidence behind genetic/epigenetic testing. Most reported familiarity with genetics (88%), but few understood differences from epigenetics (19%). Child developmental status impacted insurance concerns (p?=?0.01). There is broad parent interest in a genetic/epigenetic test for ASD. It will be crucial to carefully consider and address bioethical issues surrounding this sensitive topic while developing such technology.
En ligne :	http://dx.doi.org/10.1007/s10803-019-03990-6
Permalink :	https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=430

[article] Parent Perspectives Towards Genetic and Epigenetic Testing for Autism Spectrum Disorder [Texte imprimé et/ou numérique] / Kayla E. WAGNER, Auteur ; Jennifer B. MCCORMICK, Auteur ; Sarah BARNS, Auteur ; Molly CARNEY, Auteur ; Frank A. MIDDLETON, Auteur ; Steven D. HICKS, Auteur . - p.3114-3125.
Langues : Anglais (eng)
in Journal of Autism and Developmental Disorders > 50-9 (September 2020) . - p.3114-3125

Mots-clés :	Autism  Bioethics  Diagnosis  Epigenetics  Parent perspectives  biomarkers in autism spectrum disorder that is assigned to The Research Foundation  for the State University of New York, The Penn State Research Foundation and  Quadrant Biosciences Inc., and licensed to Quadrant Biosciences Inc. SDH is a paid  consultant for Quadrant Biosciences Inc. These conflicts of interest are actively  managed by the Penn State College of Medicine. KW and SB are employees of Quadrant  Biosciences Inc.
Index. décimale :	PER Périodiques
Résumé :	Examining community views on genetic/epigenetic research allows collaborative technology development. Parent perspectives toward genetic/epigenetic testing for autism spectrum disorder (ASD) are not well-studied. Parents of children with ASD (n?=?131), non-ASD developmental delay (n?=?39), and typical development (n?=?74) completed surveys assessing genetic/epigenetic knowledge, genetic/epigenetic concerns, motives for research participation, and attitudes/preferences toward ASD testing. Most parents (96%) were interested in saliva-based molecular testing for ASD. Some had concerns about privacy (14%) and insurance-status (10%). None (0%) doubted scientific evidence behind genetic/epigenetic testing. Most reported familiarity with genetics (88%), but few understood differences from epigenetics (19%). Child developmental status impacted insurance concerns (p?=?0.01). There is broad parent interest in a genetic/epigenetic test for ASD. It will be crucial to carefully consider and address bioethical issues surrounding this sensitive topic while developing such technology.
En ligne :	http://dx.doi.org/10.1007/s10803-019-03990-6
Permalink :	https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=430